Literature DB >> 21726481

Gastroenteritis in children.

Jacqueline R Dalby-Payne1, Elizabeth J Elliott.   

Abstract

INTRODUCTION: Acute gastroenteritis results from infection of the gastrointestinal tract, most commonly with a virus. It is characterised by rapid onset of diarrhoea with or without vomiting, nausea, fever, and abdominal pain. Diarrhoea is defined as the frequent passage of unformed, liquid stools. Regardless of the cause, the mainstay of management of acute gastroenteritis is provision of adequate fluids to prevent and treat dehydration. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent acute gastroenteritis in children? What are the effects of treatments for acute gastroenteritis in children? We searched: Medline, Embase, The Cochrane Library, and other important databases up to August 2007 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 20 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of: rotavirus vaccines for the prevention of gastroenteritis; enteral rehydration solutions (oral or gastric), lactose-free feeds, and loperamide for the treatment of gastroenteritis; and ondansetron for the treatment of vomiting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21726481      PMCID: PMC2907797     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  31 in total

1.  Estimates of morbidity and mortality rates for diarrheal diseases in American children.

Authors:  R I Glass; J F Lew; R E Gangarosa; C W LeBaron; M S Ho
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

2.  Clinical predictors of acute bacterial diarrhea in young children.

Authors:  T G DeWitt; K F Humphrey; P McCarthy
Journal:  Pediatrics       Date:  1985-10       Impact factor: 7.124

3.  Cow's milk versus soy-based formula in mild and moderate diarrhea: a randomized, controlled trial.

Authors:  U D Allen; K McLeod; E E Wang
Journal:  Acta Paediatr       Date:  1994-02       Impact factor: 2.299

4.  Lactose vs. lactose free regimen in children with acute diarrhoea: a randomized controlled trial.

Authors:  J M Lozano; J A Céspedes
Journal:  Arch Latinoam Nutr       Date:  1994-03

5.  [Lactose-free formula versus adapted formula in acute infantile diarrhea].

Authors:  F Clemente Yago; C Tapia Collados; L Comino Almenara; L López Peña; P Escrivá Tomás; J González Peraba
Journal:  An Esp Pediatr       Date:  1993-10

6.  The nutritional management of acute diarrhea in young infants: effect of carbohydrate ingested.

Authors:  C R Wall; J Webster; P Quirk; T A Robb; G J Cleghorn; G P Davidson; R W Shepherd
Journal:  J Pediatr Gastroenterol Nutr       Date:  1994-08       Impact factor: 2.839

7.  Use of nonhuman milks in the dietary management of young children with acute diarrhea: a meta-analysis of clinical trials.

Authors:  K H Brown; J M Peerson; O Fontaine
Journal:  Pediatrics       Date:  1994-01       Impact factor: 7.124

8.  Practice parameter: the management of acute gastroenteritis in young children. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis.

Authors: 
Journal:  Pediatrics       Date:  1996-03       Impact factor: 7.124

9.  Admission to hospital with gastroenteritis.

Authors:  S P Conway; R R Phillips; S Panday
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

10.  Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis.

Authors:  Su-Ting T Li; David C Grossman; Peter Cummings
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.